Literature DB >> 16052326

Immunological characteristics of diabetes in schizophrenia.

Dan Cohen, M R Batstra, C C Gispen-de Wied.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16052326     DOI： 10.1007/s00125-005-1879-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values.

Authors:  M R Batstra; A van Driel; J S Petersen; C A van Donselaar; M J van Tol; G J Bruining; D E Grobbee; T Dyrberg; H J Aanstoot
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

2.  Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study.

Authors:  J B Ruige; M R Batstra; H J Aanstoot; L M Bouter; G J Bruining; J N De Neeling; R J Heine
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.

Authors:  M Pietropaolo; E Barinas-Mitchell; S L Pietropaolo; L H Kuller; M Trucco
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

4.  Clozapine-associated diabetes.

Authors:  E Koller; B Schneider; K Bennett; G Dubitsky
Journal:  Am J Med       Date:  2001-12-15       Impact factor: 4.965

5.  Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands.

Authors:  M R Batstra; J S Petersen; G J Bruining; D E Grobbee; S A de Man; J L Molenaar; T Dyrberg; H J Aanstoot
Journal:  Hum Immunol       Date:  2001-10       Impact factor: 2.850

Review 6.  Olanzapine-associated diabetes mellitus.

Authors:  Elizabeth A Koller; P Murali Doraiswamy
Journal:  Pharmacotherapy       Date:  2002-07       Impact factor: 4.705

7.  A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.

Authors:  Elizabeth A Koller; Jena Weber; P Murali Doraiswamy; Bruce S Schneider
Journal:  J Clin Psychiatry       Date:  2004-06       Impact factor: 4.384

8.  Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia.

Authors:  Mythily Subramaniam; Siow-Ann Chong; Elaine Pek
Journal:  Can J Psychiatry       Date:  2003-06       Impact factor: 4.356

Review 9.  Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.

Authors:  D Cohen
Journal:  Pharmacopsychiatry       Date:  2004-01       Impact factor: 5.788

10.  Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Authors:  Jean-Pierre Lindenmayer; Pal Czobor; Jan Volavka; Leslie Citrome; Brian Sheitman; Joseph P McEvoy; Thomas B Cooper; Miranda Chakos; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112
View more
  5 in total

Review 1.  Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

Authors:  Leslie Citrome; Richard I G Holt; Daniel J Walker; Vicki Poole Hoffmann
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.

Authors:  Christoffer Polcwiartek; Kristian Kragholm; Christopher Rohde; Nasseh Hashemi; Torkel Vang; Jimmi Nielsen
Journal:  Diabetologia       Date:  2017-06-07       Impact factor: 10.122

Review 3.  Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.

Authors:  Christoffer Polcwiartek; Torkel Vang; Christina Hedegård Bruhn; Nasseh Hashemi; Mary Rosenzweig; Jimmi Nielsen
Journal:  Psychopharmacology (Berl)       Date:  2016-09-04       Impact factor: 4.530

Review 4.  Diabetes mellitus and severe mental illness: mechanisms and clinical implications.

Authors:  Richard I G Holt; Alex J Mitchell
Journal:  Nat Rev Endocrinol       Date:  2014-12-02       Impact factor: 43.330

Review 5.  Association Between Antipsychotic Medication Use and Diabetes.

Authors:  Richard I G Holt
Journal:  Curr Diab Rep       Date:  2019-09-02       Impact factor: 4.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.